Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

RETT strategy What happens if the FDA fails to approve blarcamesine, after statistically significant data from any of the three clinical trials appear, showing both safety and efficacy?

That I think is the whole reason for the Rett strategy. No one paying that much attention to an orphan disease, easier approval when no existing treatment. Legitimize 273, then spring the alz data, get Aussie approval.

Then how can the FDA say not to a drug they already approved for Rett? Especially when alz patients start clamoring for it.

A well thought out strategy by Dr. M to get by big pharma.